Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP478412.RAXK6d3wR-AYDvT7uac656DsU_qLZHSOYXNa0i_SGBEmc130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478412.RAXK6d3wR-AYDvT7uac656DsU_qLZHSOYXNa0i_SGBEmc130_provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP719160.RAXI5_t1IvX7kODSgP2jTflygFcM67gZvNo3Hnv-z6f5Y130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719160.RAXI5_t1IvX7kODSgP2jTflygFcM67gZvNo3Hnv-z6f5Y130_provenance.
• NP715905.RAugTysVSvUfK5x8wkkAQOF_4JGtXLjJY_qyE2HhAfYng130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715905.RAugTysVSvUfK5x8wkkAQOF_4JGtXLjJY_qyE2HhAfYng130_provenance.
• NP102010.RAxTqcmmjWpbV_3RdJUPcKZVmO9nexVGCzolTl5V-KlKY130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102010.RAxTqcmmjWpbV_3RdJUPcKZVmO9nexVGCzolTl5V-KlKY130_provenance.
• NP123747.RA9yX2vTP6ib2EynBavfaJiU9tOF0nLViEwmkEQHUh6ks130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123747.RA9yX2vTP6ib2EynBavfaJiU9tOF0nLViEwmkEQHUh6ks130_provenance.
• NP478392.RAO77sDqYYmU3KgpeSTiRqvWPV7X6GI_EZvi3go4aEKXY130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478392.RAO77sDqYYmU3KgpeSTiRqvWPV7X6GI_EZvi3go4aEKXY130_provenance.
• NP140459.RAMPivrGFtUysroCX3PIOpcuzMvEUgh1J8j81HyWC85WI130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140459.RAMPivrGFtUysroCX3PIOpcuzMvEUgh1J8j81HyWC85WI130_provenance.
• NP719161.RALiY0xGXdy9-1QmN4sjuhk6zPFfklDRXwxkbzwbMzj4I130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719161.RALiY0xGXdy9-1QmN4sjuhk6zPFfklDRXwxkbzwbMzj4I130_provenance.
• NP719162.RAMeXZYrrdWpDYrtg4w-cjGHYVsxOlnD6XMWgLKklU2P8130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719162.RAMeXZYrrdWpDYrtg4w-cjGHYVsxOlnD6XMWgLKklU2P8130_provenance.
• NP715895.RA7jJN46iTFSqzLaHcXknrYrZZ61YMh4zJtDDm4ZzkpjA130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715895.RA7jJN46iTFSqzLaHcXknrYrZZ61YMh4zJtDDm4ZzkpjA130_provenance.
• NP140451.RA_I0x9F_uyzZsz70f79kXGa6eCD8yTdxSJkw3gg0vwrU130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140451.RA_I0x9F_uyzZsz70f79kXGa6eCD8yTdxSJkw3gg0vwrU130_provenance.
• NP719163.RA4aiQuiEQHlOejX5NKTvtjp47pOsuJSL8ffL6yLQ2q8M130_assertion description "[In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719163.RA4aiQuiEQHlOejX5NKTvtjp47pOsuJSL8ffL6yLQ2q8M130_provenance.